ML20133L877

From kanterella
Revision as of 19:23, 3 July 2020 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Amend 6 to License 50-19913-01 for Ketohikan General Hosp, Changing Condition 12 Re Listed Authorized Users of Licensed Matl
ML20133L877
Person / Time
Site: 03019521
Issue date: 08/07/1985
From: Riedlinger B
NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V)
To:
Shared Package
ML20133L879 List:
References
50-19913-01, 50-19913-1, NUDOCS 8510240353
Download: ML20133L877 (1)


See also: IR 05000199/2013001

Text

- ,

en=L====AA=_=_=======_====.========_=====A=A========.-=========

Rc Form 374A U.S. NUCLEA"3 CE!ULATORY COMMIS$10N pgg 1 gy 1 pg  ;

Lkenee number

50-19913-01 -

. MATERIALS LICENSE Docket or nererene. number

SUPPLEMENTARY SHEET

, 030-19521  :

'

I'

Amendment No. 6 I

,

h

!

I

!

Katchikan General Hospital c

I 3100 Tongass Avenue f

l Katchikan Alaska 99901  !;

i r

j In accordance with letter dated August 5, 1985 from Sister Barbara llaase, g

Administrator, License humber 50-19913-01 is amended as follows: p

l

i p

! License Conditiot 12. is amended to read: F

u

t

] -. n e-- -

j 12. Licensed material listed in Itesw6 aboyeiin- Authorized fut use by, or under the L:

supervision of, the followingdad'i iduals foPtN/u'aterinis and uses indicated:

'

j l;

i

I Stuart A. O'Byrne M.D; Q *v " 'y , n

Groups 1. II, and III n

l

In_vitrostudie'sQ

l T Xenon 133

Phosphorus 32 as sol ble phosphate for

[

-x

9- s

J treatmenthot polycythemta vera,

!:

r:

k/ lY6,h

b\

_ leukemiAi and bone metastases

(>

I

! [w / p

! Donsid Klein, H.D,,  :

> Is>f [Jcg / p 1' Groups 1.iII,and111Q

, fJ

! N , s f % In\ vitro studies .

] V~ t Q f"^ E non.133 j j, <f

-! g) ((#y ' ,L, Ah

1

i ve *% (Phosphorus

j 32.,,as solutiTo

t'reatinent f of polycythemia vera, phosphate

,

u

i

.C

,

Qn '%y)%:,y

'

.;; a

leuk emia ,' and ' bone ,"cieta stases

u[ a ; H; L S e

I Louise Isenbetg-Dallaire ;M/D.! P WGroupsTrill, and 11i3  ?

l g *

h [/. J fn' vitro / studies 4

W

$

M. X} don 133 ll

l

John C. Jovett, M.D. h Croups I., II, hd III

K i 1; *pg,xenos;133

, L tro': studies

i

C

,

o n

! k

i

h

l k

l FOR THE U.S. NUCLEAR REGULATORY COMMISSION h

!

I

i

!

l

j

4@e' trd :t  :

Date AUG 7 1985 ny  ;

Beth A. Riedlinger

I

llealth Physicist (Licensing)

Nuc1 car Materials safety Section b;

B51024 B50007

REG 5 L Region V  ;

50-19913-01 PDM

ML

_________________________________.,_____s

50 [  ;

,,,__=_________